Park Ha Biological Technology (BYAH) Ratios
Park Ha Biological Technology Ratios
BYAH's free cash flow for Q2 2026 was $-338.79K. For the 2026 fiscal year, BYAH's free cash flow was decreased by $-225.06K and operating cash flow was $-113.73K. See a summary of the company’s cash flow.
| Ratios | Oct 25 | Oct 24 | Oct 23 | Oct 22 | Oct 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.92 | 1.87 | 1.75 | 0.96 | 0.41 |
| Quick Ratio | 2.88 | 1.82 | 1.67 | 0.92 | 0.14 |
| Cash Ratio | 2.01 | 0.36 | 0.83 | 0.24 | 0.06 |
| Solvency Ratio | -12.39 | 0.32 | 0.70 | 0.09 | -0.38 |
| Operating Cash Flow Ratio | 0.05 | 0.63 | 0.10 | 0.61 | -0.43 |
| Short-Term Operating Cash Flow Coverage | 0.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 3.54M | $ 1.27M | $ 923.75K | $ -103.81K | $ -698.81K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.02 | 0.01 | 0.01 | 0.06 |
| Debt-to-Equity Ratio | 0.05 | 0.05 | 0.03 | 0.17 | -0.06 |
| Debt-to-Capital Ratio | 0.04 | 0.04 | 0.03 | 0.15 | -0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.49 | 2.05 | 2.24 | 16.76 | -1.03 |
| Debt Service Coverage Ratio | -232.56 | 0.00 | 0.00 | 1144.24 | -372.49 |
| Interest Coverage Ratio | -588997.59 | 0.00 | 0.00 | 1015.59 | -419.58 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.45 | 0.13 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.15 | -0.58 | -0.83 | -2.49 | 0.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 94.36% | 91.80% | 87.35% | 73.47% | 66.58% |
| EBIT Margin | -953.88% | 33.32% | 48.01% | 9.91% | -51.96% |
| EBITDA Margin | -949.55% | 34.28% | 48.82% | 11.50% | -47.77% |
| Operating Profit Margin | -956.45% | 33.32% | 48.01% | 10.26% | -53.81% |
| Pretax Profit Margin | -953.89% | 33.31% | 48.05% | 9.90% | -52.09% |
| Net Profit Margin | -965.00% | 20.09% | 34.65% | 9.97% | -52.09% |
| Continuous Operations Profit Margin | -965.00% | 20.09% | 34.65% | 9.97% | -52.09% |
| Net Income Per EBT | 101.17% | 60.32% | 72.11% | 100.68% | 100.00% |
| EBT Per EBIT | 99.73% | 99.96% | 100.09% | 96.44% | 96.80% |
| Return on Assets (ROA) | -409.31% | 15.52% | 37.62% | 7.60% | -81.61% |
| Return on Equity (ROE) | -609.90% | 31.78% | 84.15% | 127.30% | 83.88% |
| Return on Capital Employed (ROCE) | -593.23% | 50.92% | 115.52% | 131.11% | 89.09% |
| Return on Invested Capital (ROIC) | -578.41% | 30.37% | 81.55% | 111.65% | 92.26% |
| Return on Tangible Assets | -409.77% | 15.56% | 37.76% | 7.62% | -81.61% |
| Earnings Yield | -220.91% | 3.81% | 6.79% | 1.52% | -3.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.94 | 2.15 | 3.46 | 1.26 | 11.68 |
| Payables Turnover | 11.86 | 8.12 | 1.58 | 3.92 | 3.48 |
| Inventory Turnover | 1.68 | 2.73 | 3.24 | 5.41 | 0.98 |
| Fixed Asset Turnover | 7.46 | 13.63 | 34.91 | 30.55 | 8.72 |
| Asset Turnover | 0.42 | 0.77 | 1.09 | 0.76 | 1.57 |
| Working Capital Turnover Ratio | 1.02 | 2.11 | 5.93 | -4.88 | 0.00 |
| Cash Conversion Cycle | 374.23 | 258.65 | -13.38 | 264.64 | 297.72 |
| Days of Sales Outstanding | 188.34 | 170.05 | 105.50 | 290.13 | 31.25 |
| Days of Inventory Outstanding | 216.65 | 133.58 | 112.52 | 67.51 | 371.28 |
| Days of Payables Outstanding | 30.76 | 44.97 | 231.40 | 92.99 | 104.80 |
| Operating Cycle | 404.99 | 303.62 | 218.02 | 357.63 | 402.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.17 | 1.83 | 0.00 | 0.06 | -0.02 |
| Free Cash Flow Per Share | -0.04 | 1.67 | 0.00 | 0.05 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.97 | 11.22 | 5.58 | 121.30 | -38.57 |
| Capital Expenditure Coverage Ratio | 0.97 | 11.22 | 5.58 | 121.30 | -38.57 |
| Operating Cash Flow Coverage Ratio | 0.48 | 13.66 | 4.02 | 55.06 | -14.14 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.40 | 0.05 | 0.75 | -0.53 |
| Free Cash Flow Yield | -0.03% | 6.97% | 0.83% | 11.40% | -4.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.45 | 26.22 | 14.73 | 65.60 | -25.88 |
| Price-to-Sales (P/S) Ratio | 4.37 | 5.27 | 5.10 | 6.54 | 13.48 |
| Price-to-Book (P/B) Ratio | 2.76 | 8.33 | 12.40 | 83.51 | -21.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3713.61 | 14.34 | 120.83 | 8.77 | -24.57 |
| Price-to-Operating Cash Flow Ratio | 128.47 | 13.07 | 99.18 | 8.70 | -25.21 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.60 | 0.04 | -0.47 | 0.00 |
| Enterprise Value Multiple | -0.31 | 14.79 | 9.62 | 54.38 | -28.13 |
| Enterprise Value | 7.42M | 12.07M | 11.55M | 12.00M | 12.51M |
| EV to EBITDA | -0.31 | 14.79 | 9.62 | 54.38 | -28.13 |
| EV to Sales | 2.94 | 5.07 | 4.70 | 6.25 | 13.44 |
| EV to Free Cash Flow | -2498.96 | 13.80 | 111.18 | 8.39 | -24.50 |
| EV to Operating Cash Flow | 86.45 | 12.57 | 91.26 | 8.32 | -25.13 |
| Tangible Book Value Per Share | 54.18 | 2.86 | 0.04 | 0.01 | -0.02 |
| Shareholders’ Equity Per Share | 54.27 | 2.87 | 0.04 | 0.01 | -0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.40 | 0.28 | -0.01 | 0.00 |
| Revenue Per Share | 34.30 | 4.55 | 0.09 | 0.07 | 0.04 |
| Net Income Per Share | -331.01 | 0.91 | 0.03 | 0.01 | -0.02 |
| Tax Burden | 1.01 | 0.60 | 0.72 | 1.01 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.09 | 0.02 | 0.01 | 0.03 | 0.00 |
| SG&A to Revenue | 10.34 | 0.49 | 0.20 | 0.37 | 0.81 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.00 | 2.01 | 0.15 | 7.54 | 1.03 |
Currency in USD